We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+1.83%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$329M
AUM Growth
-$177M
Cap. Flow
-$118M
Cap. Flow %
-35.7%
Top 10 Hldgs %
93.53%
Holding
42
New
10
Increased
5
Reduced
10
Closed
15

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$12.8M
2
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$11.1M
3
WGS icon
GeneDx Holdings
WGS
+$5.43M
4
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$5.32M
5
IMMP
Immutep
IMMP
+$1.44M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$105M
2
QDEL icon
QuidelOrtho
QDEL
+$21.3M
3
ARKK icon
ARK Innovation ETF
ARKK
+$16.6M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$11.5M
5
AGEN
Agenus
AGEN
+$7.49M

Sector Composition

Rank Sector Weight
1 Healthcare 97.79%
2 Energy 0.18%
3 Industrials 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
26
CALL
Acadia Pharmaceuticals
ACAD
$5.03B
$48K 0.01%
+300,000
New +$5.6M
VLD
27
DELISTED
Velo3D, Inc.
VLD
$42K 0.01%
+868
New +$102K
ABUS icon
28
Arbutus Biopharma
ABUS
$915M
– –
-50,000
Closed -$149K
ACAD icon
29
Acadia Pharmaceuticals
ACAD
$5.03B
– –
-186,789
Closed -$3.49M
ACAD icon
30
PUT
Acadia Pharmaceuticals
ACAD
$5.03B
– –
-459,300
Closed -$1.06M
ARKK icon
31
ARK Innovation ETF
ARKK
$6.31B
– –
-250,000
Closed -$16.6M
BCRX icon
32
PUT
BioCryst Pharmaceuticals
BCRX
$2.4B
– –
-550,000
Closed -$1.26M
CNC icon
33
PUT
Centene
CNC
$32.5B
– –
-300,000
Closed -$1.49M
IBRX icon
34
ImmunityBio
IBRX
$8.1B
– –
-400,013
Closed -$2.24M
LABU icon
35
PUT
Direxion Daily S&P Biotech Bull 3X ETF
LABU
$603M
– –
-50,000
Closed -$1.77M
OPK icon
36
PUT
Opko Health
OPK
$1.02B
– –
-749,900
Closed -$292K
PFE icon
37
PUT
Pfizer
PFE
$153B
– –
-550,000
Closed -$1.26M
PTIX
38
DELISTED
Performance Technologies
PTIX
– –
-357
Closed -$16K
QDEL icon
39
PUT
QuidelOrtho
QDEL
$838M
– –
-26,500
Closed -$200K
DMTK
40
PUT
DELISTED
DermTech, Inc. Common Stock
DMTK
– –
-193,800
Closed -$921K
ATRS
41
DELISTED
Antares Pharma, Inc.
ATRS
– –
-1,720,000
Closed -$7.05M
BHVN
42
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-20,000
Closed -$212K
1
2

Similar funds

EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM
CWA
Clearview Wealth Advisors Salem, Oregon $158M AUM 14.25% 1-Year Est. Return
SW
Schulz Wealth Mansfield, Texas $156M AUM 13.29% 1-Year Est. Return

Oracle Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Oracle Investment Management held 42 positions worth $329M, down 35% from $506M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Oracle Investment Management withdrew a net $118M in Q2 2022, closing 15 positions and reducing 10 holdings. Its most notable exit was ARK Innovation ETF, an estimated $16.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier, followed by Energy and Industrials.

Against the trend, Oracle Investment Management opened a new position in Moderna worth $12.8M.

  • Oracle Investment Management's largest Q2 2022 buy was Moderna: 89,700 shares worth $12.8M.
  • Oracle Investment Management added most to GeneDx Holdings in Q2 2022, an estimated $5.43M increase.
  • Oracle Investment Management's biggest Q2 2022 reduction was Biohaven Pharmaceutical Holding Company Ltd., cutting an estimated $105M.
  • Oracle Investment Management fully exited ARK Innovation ETF in Q2 2022, selling an estimated $16.6M.
  • Oracle Investment Management's ten largest holdings make up 94% of its $329M portfolio in Q2 2022.
  • Oracle Investment Management opened 10 new positions and closed 15 in Q2 2022.
  • Oracle Investment Management's portfolio value fell 35% quarter-over-quarter to $329M.

Based on Oracle Investment Management's 13F filing for Q2 2022, filed 15 Aug 2022.